Literature DB >> 32943631

Author Correction: A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics.

Michael A Crone1,2,3, Miles Priestman1,2, Marta Ciechonska1,2, Kirsten Jensen1,2,3, David J Sharp3,4, Arthi Anand5,6, Paul Randell7,8, Marko Storch1,2, Paul S Freemont9,10,11.   

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Entities:  

Year:  2020        PMID： 32943631      PMCID： PMC7498595          DOI： 10.1038/s41467-020-18720-1

Source DB:  PubMed          Journal:  Nat Commun        ISSN： 2041-1723            Impact factor:   14.919


Correction to: Nature Communications 10.1038/s41467-020-18130-3, published online 08 September 2020. The original version of this manuscript did not include a link to the RNA Extraction Procotol scripts that are publically available at Zenodo. The scripts can be found at the following URL: 10.5281/zenodo.4021454 In addition, the original version of this Article omitted a declaration from the Competing Interests statement, which should have included the following: “M. Priestman and M. Ciechonska are co-founders of Salient Labs. All other authors declare no competing interests.” This has now been corrected in both the PDF and HTML versions of the Article.
  1 in total

1.  Optimized protocol for a quantitative SARS-CoV-2 duplex RT-qPCR assay with internal human sample sufficiency control.

Authors:  Aileen G Rowan; Philippa May; Anjna Badhan; Carolina Herrera; Patricia Watber; Rebecca Penn; Michael A Crone; Marko Storch; Jeremy A Garson; Myra McClure; Paul S Freemont; Pinglawathee Madona; Paul Randell; Graham P Taylor
Journal:  J Virol Methods       Date:  2021-05-10       Impact factor: 2.014
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.